封面
市场调查报告书
商品编码
1775380

医疗包装薄膜市场:未来预测(2025-2030)

Medical Packaging Films Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计医疗包装薄膜市场规模将从 2025 年的 85.44 亿美元成长到 2030 年的 117.63 亿美元,复合年增长率为 6.60%。

由于对生物技术注射药物的需求不断增长以及医疗和製药行业的不断扩张,医用包装薄膜市场正在经历强劲增长。这些药物通常对热敏感,需要能够确保产品保护、品质、防篡改和患者安全的包装解决方案,而无需依赖高温末端稳定製程。医用包装薄膜在满足这些需求并为药品包装提供可靠且高效的解决方案方面发挥关键作用。

市场驱动因素

  • 政府措施和医疗保健投资

政府对先进医疗系统的投资是医用包装薄膜市场的主要驱动力。例如,在韩国,超过一半的医疗支出由国家和州政府资助,国民健康保险 (NHI) 涵盖约 96% 的人口,占医疗总支出的近一半。这提高了医疗服务的可用性和可近性,刺激了对医疗包装解决方案的需求。同样,在澳大利亚,医疗保健支出预计将在 2024 年达到 1,810 亿美元,年增 6%,其中超过三分之二由联邦和州政府资助。医疗保险福利计划 (MBS) 和药品福利计划 (PBS) 等项目津贴基层医疗并吸引私人投资于医疗设备和包装。预计这些政策将透过鼓励创新和采用先进的包装解决方案来推动未来五年的市场成长。

市场区隔

  • 聚丙烯的优点

聚丙烯 (PP) 凭藉其环保特性和优异的防潮性能,在医药包装行业中获得了广泛认可,占据了相当大的市场占有率。在欧洲等法律限制焚烧聚氯乙烯( PVC) 的地区,PP 正逐渐取代聚氯乙烯 (PVC)。 PP 适用于泡壳包装,其强大的防潮性能也促使其在医药应用领域广泛采用。例如,主要企业(SIBUR) 推出了一种基于 PP 的新型包装解决方案,该解决方案采用了专为医药行业泡壳包装量身定制的 Millad NX 8000。预计对 PP 的持续投资将进一步提升其在市场上的主导地位。

区域成长:亚太地区领先

亚太地区是医疗包装薄膜市场的主要成长引擎,这得益于不断提升的健康意识以及公共和私营部门的大量投资。该地区拥有一些全球最大的医药包装公司,并受益于丰富的原材料和低廉的生产成本。

本报告的主要优点

  • 深刻分析:获得涵盖主要地区和新兴地区的深入市场洞察,重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局:了解全球主要企业采取的策略策略,并了解正确策略带来的潜在市场渗透。
  • 市场驱动因素和未来趋势:探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
  • 可行的建议:利用洞察力进行策略决策,在动态环境中开闢新的业务流和收益。
  • 适用范围广:对于新兴企业、研究机构、顾问公司、中小企业和大型企业来说,它都是实用且具有成本效益的。

它有什么用途?

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

分析范围

  • 历史资料(2022-2024)和预测资料(2025-2030)
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按部门和地区(国家)分類的收益成长和预测分析
  • 公司概况(策略、产品、财务资讯、主要趋势等)

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业景气

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 法律规范
  • 策略建议

第四章 技术展望

第五章 全球医用包装薄膜市场(依材料)

  • 介绍
  • 聚丙烯(PP)
  • 聚乙烯(PE)
  • 聚酰胺(PA)
  • 生物分解性/生物基薄膜(例如 PLA、PHA)
  • 其他的

6 全球医用包装薄膜市场依薄膜类型划分

  • 介绍
  • 热成型膜
  • 高阻隔膜
  • 无菌阻隔膜
  • 其他的

第七章全球医用包装薄膜市场应用

  • 介绍
  • 包包
  • 管子
  • 泡壳包装
  • 袋子和盖子
  • 其他的

8. 全球医疗包装薄膜市场(依最终用户)

  • 介绍
  • 製药公司
  • 医疗设备製造商
  • 医院和诊所

9. 全球医疗包装薄膜市场(按地区)

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第十章 竞争格局

  • 主要企业和策略分析
  • 市场占有率分析
  • 企业合併(M&A)、协议与合作
  • 竞争仪錶板

第十一章 公司简介

  • Amcor plc
  • DuPont de Nemours, Inc.
  • Berry Global Group, Inc.
  • 3M Company
  • Honeywell International LLC
  • Wipak Oy
  • Renolit SE
  • Weigao Group
  • Covestro AG
  • POLYCINE GmbH
  • Sealed Air Corporation

第十二章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061613424

The Medical Packaging Films Market is expected to grow from USD 8.544 billion in 2025 to USD 11.763 billion in 2030, at a CAGR of 6.60%.

The medical packaging films market is experiencing robust growth, driven by the increasing demand for biotechnology-based injectable drugs and expanding healthcare and pharmaceutical sectors. These drugs, often heat-sensitive, require packaging solutions that ensure product protection, quality, tamper-evidence, and patient safety without relying on high-heat terminal stabilization processes. Medical packaging films are critical in meeting these needs, offering reliable and efficient solutions for pharmaceutical packaging.

Market Growth Drivers

  • Government Initiatives and Healthcare Investment

Government investments in advanced healthcare systems are a key driver of the medical packaging films market. In South Korea, for instance, over half of healthcare spending is funded by national and state governments, with the National Healthcare Insurance (NHI) covering approximately 96% of the population and nearly half of total healthcare costs. This enhances affordability and access to healthcare services, spurring demand for medical packaging solutions. Similarly, in Australia, healthcare spending reached $181 billion in 2024, a 6% increase from the previous year, with over two-thirds funded by federal and state governments. Programs like the Medicare Benefits Scheme (MBS) and Pharmaceutical Benefits Scheme (PBS) subsidize primary care and ensure affordability, attracting private investment in medical equipment and packaging. These policies are expected to drive market growth over the next five years by fostering innovation and adoption of advanced packaging solutions.

Market Segment Analysis

  • Dominance of Polypropylene

Polypropylene (PP) is gaining significant traction in the pharmaceutical packaging industry, holding a substantial market share due to its eco-friendly properties and excellent moisture-barrier capabilities. It is increasingly replacing polyvinyl chloride (PVC) in regions like Europe, where legislation restricts PVC incineration. PP's suitability for blister packaging, which provides robust moisture protection, has fueled its adoption in pharmaceutical applications. For example, SIBUR, a leading Russian company, introduced new PP-based packaging solutions incorporating Millad NX 8000, tailored for blister packaging in the pharmaceutical sector. Continued investments in PP are expected to further bolster its dominance in the market.

Regional Growth: Asia Pacific Leading the Way

The Asia Pacific region is a major growth engine for the medical packaging films market, driven by rising health awareness and significant investments from both public and private sectors. The region hosts some of the world's largest pharmaceutical packaging companies, benefiting from abundant raw materials and low production costs.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Key Market Segmentation:

By Material

  • Polypropylene (PP)
  • Polyethene (PE)
  • Polyamide (PA)
  • Biodegradable/Bio-based Films (e.g., PLA, PHA)
  • Others

By Film Type

  • Thermoformable Films
  • High Barrier Films
  • Sterile Barriers films
  • Others

By Application

  • Bags
  • Tubes
  • Blister Packs
  • Pouches & Lidding Films
  • Others

By End-User

  • Pharmaceutical Companies
  • Medical Device Manufacturers
  • Hospitals & Clinics

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • UAE
  • Saudi Arabia
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Regulatory Framework
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL MEDICAL PACKAGING FILMS MARKET BY MATERIAL

  • 5.1. Introduction
  • 5.2. Polypropylene (PP)
  • 5.3. Polyethene (PE)
  • 5.4. Polyamide (PA)
  • 5.5. Biodegradable/Bio-based Films (e.g., PLA, PHA)
  • 5.6. Others

6. GLOBAL MEDICAL PACKAGING FILMS MARKET BY FILM TYPE

  • 6.1. Introduction
  • 6.2. Thermoformable Films
  • 6.3. High Barrier Films
  • 6.4. Sterile Barriers Films
  • 6.5. Others

7. GLOBAL MEDICAL PACKAGING FILMS MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Bags
  • 7.3. Tubes
  • 7.4. Blister Packs
  • 7.5. Pouches & Lidding Films
  • 7.6. Others

8. GLOBAL MEDICAL PACKAGING FILMS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Pharmaceutical Companies
  • 8.3. Medical Device Manufacturers
  • 8.4. Hospitals & Clinics

9. GLOBAL MEDICAL PACKAGING FILMS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Others

10. COMPETITIVE LANDSCAPE

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Amcor plc
  • 11.2. DuPont de Nemours, Inc.
  • 11.3. Berry Global Group, Inc.
  • 11.4. 3M Company
  • 11.5. Honeywell International LLC
  • 11.6. Wipak Oy
  • 11.7. Renolit SE
  • 11.8. Weigao Group
  • 11.9. Covestro AG
  • 11.10. POLYCINE GmbH
  • 11.11. Sealed Air Corporation

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations